|
2024
|
Invention
|
Compositions for producing recombinant virus.
The present disclosure relates to compositions and... |
|
2023
|
Invention
|
Rrx-001 for treating reproductive-related disorders. Methods and pharmaceutical compositions for ... |
|
|
Invention
|
Rrx-001 for the treatment of a hemoglobinopathy. Methods and compositions for the treatment of a ... |
|
|
Invention
|
Rrx-001 for minimizing post-infarct adverse ventricular remodeling and complications. Composition... |
|
|
Invention
|
Human il-10 receptor alpha fusion proteins.
Provided is a fusion protein, e.g., a cytokine recep... |
|
|
Invention
|
Compositions and methods for parenteral administration of therapeutic agents.
The invention prov... |
|
|
Invention
|
Adenoviral vectors encapsulated in cationic liposomes, and preparation and use thereof. The prese... |
|
|
Invention
|
Methods and compositions utilizing rrx-001 combination therapy for radioprotection.
Provided her... |
|
|
Invention
|
Compositions and methods for reducing adverse side effects in cancer treatment. Compositions and ... |
|
|
Invention
|
Systems and methods to improve exercise tolerance. Methods and combinations for enhancing physica... |
|
|
Invention
|
Compositions and methods for treatment of pulmonary hypertension. A method of treating pulmonary ... |
|
|
Invention
|
Co-crystals of 2-bromo-1-(3,3-dinitroazetidin-1-yl)ethanone and methods. The present disclosure r... |
|
|
Invention
|
Methods and compositions comprising a nitrite-reductase promoter for treatment of medical disorde... |
|
|
Invention
|
Compositions and methods for treatment of nafld and nash and related dyslipidemias. Compositions ... |
|
2022
|
Invention
|
Compositions and methods for intravenous administration of 2-bromo-1-(3,3-dinitroazetidin-1-yl)et... |
|
|
Invention
|
Organonitro and sulfoxyalkyl organonitro compounds for use in treating medical disorders.
Provid... |
|
|
Invention
|
Organonitro and sulfoxyalkyl organonitro compounds for use in treating medical disorders. Provide... |
|
|
Invention
|
Crystalline abdnaz compositions and methods of making and using the same.
The present invention ... |
|
|
Invention
|
Crystalline abdnaz compositions and methods of making and using the same. The present invention r... |
|
|
Invention
|
Recombinant adenoviruses carrying transgenes.
Disclosed herein are recombinant adenoviruses with... |
|
2021
|
G/S
|
Pharmaceutical products, preparations, and substances for the prevention and treatment of cancer,... |
|
|
G/S
|
Pharmaceutical products, preparations, and substances for
the prevention and treatment of cancer... |
|
|
Invention
|
Immunomodulatory oncolytic adenoviral vectors, and methods of production and use thereof for trea... |
|
|
Invention
|
Mono- and multi-valent sars-cov-
2 adenoviral vector vaccines and
sars-cov-2 immune globulin and
... |
|
|
Invention
|
Mono- and multi-valent sars-cov-2 adenoviral vector vaccines and sars-cov-2 immune globulin and m... |
|
|
Invention
|
Treatment of gliomas using organonitro compound combination therapy. The invention provides thera... |
|
|
Invention
|
Immunomodulatory fusion proteins. Provided is a fusion protein, e.g., a cytokine receptor fusion ... |
|
2019
|
Invention
|
Treatment of gliomas using organonitro compound combination therapy.
The invention provides ther... |
|
|
Invention
|
Methods and compositions for targeting cancer cells for treatment. The invention relates to compo... |
|
|
Invention
|
Treatment of brain metastases using organonitro compound combination therapy. The invention provi... |
|
|
Invention
|
Medication infusion devices, systems, and methods. Devices, systems, and methods for medication i... |
|
|
Invention
|
Personalized cancer vaccines.
The invention provides for a recombinant adenoviral vector compris... |
|
|
Invention
|
Personalized cancer vaccines. The invention provides for a recombinant adenoviral vector comprisi... |
|
|
Invention
|
Methods and compositions for treating cancer and sensitizing tumor cells to kinase inhibitors. Th... |
|
|
Invention
|
Methods and compositions utilizing rrx-001 for radioprotection.
Provided herein are therapeutic ... |
|
|
Invention
|
Methods and compositions utilizing rrx-001 combination therapy for radioprotection. Provided here... |
|
2018
|
Invention
|
Human il-10 receptor alpha fusion proteins. Provided is a fusion protein, e.g., a cytokine recept... |
|
|
Invention
|
Compositions and methods for parenteral administration of therapeutic agents. The invention provi... |
|
|
Invention
|
Anti-angiogenic adenovirus.
The invention relates to a recombinant adenovirus that expresses end... |
|
|
Invention
|
Multiple transgene recombinant adenovirus. The invention relates to a recombinant adenovirus comp... |
|
|
Invention
|
Method for producing recombinant oncolytic adenovirus with modified e1a cancer-specific promoter.... |
|
|
Invention
|
Tumor selective tata-box and caat-box mutants.
The invention provides, e.g., a recombinant virus... |
|
|
Invention
|
Multiple transgene recombinant adenovirus.
The invention provides a recombinant adenovirus compr... |
|
2017
|
Invention
|
Sulfoxyalkyl organonitro and related compounds and pharmaceutical compounds for use in medicine. ... |
